Teres Bio, Inc is a clinical stage life sciences company within the Aditum Bio portfolio of companies.

Teres Bio translates discoveries in inflammatory pathways into novel, topical therapies for skin diseases.

Our Focus

Chronic skin disorders that impact over 100 million people worldwide, with high unmet need for innovative topical therapies

Pipeline

TER-101, a novel mechanism of action, targeting inflammatory pathways in skin disease